Explore our data

Trials, drugs, companies, conditions and targets, with every value linked to its source.

Trials

Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery NCT03244072
Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older NCT06447779
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell) NCT07272434
MVA-BN-RSV Vaccine Trial NCT05238025
LIBREXIA-AF NCT05757869
Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness NCT06282315
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years NCT06041061
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) NCT06292013
VICTORION-2P NCT05030428
SURMOUNT-MMO NCT05556512
ROXI-EVEREST NCT07626411
AZURE-Outcomes NCT07000357
OCEANIC-AF NCT05643573
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes NCT06008756
LIBREXIA-ACS NCT05754957
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. NCT05739383
NextCOVE NCT05815498
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years NCT05262010
MARITIME-CV NCT07037433
LIBREXIA-STROK NCT05702034
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine NCT05669625
A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell) NCT07293065
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease NCT07064473
Prevent-HF NCT06677060
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) NCT06531824
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events NCT07136012
ZENITH NCT07181109
MOVE-Lp(a) NCT07157774
COVID-19 NCT05096832
ANCHOR NCT07159763
ARTEMIS NCT06118281
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) NCT06383390
Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older NCT05812014
PREVAIL NCT05202509
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine NCT06291857
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males NCT06465914
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. NCT06178991
Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052) NCT05285826
Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life NCT05437510
EMBER-4 NCT05514054
Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha) NCT05916326
The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older NCT06015282
Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov) NCT05398848
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial NCT05581303
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) NCT07241390
MTBVACN3 NCT04975178
REDEFINE 3 NCT05669755
ROXI-PALISADE NCT07318610
Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination NCT07133802
Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) NCT06524947
VICTOR NCT05093933
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure NCT06424288
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies NCT07160244
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) NCT07517263
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) NCT06077864
CAMBRIA-2 NCT05952557
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer NCT07349069
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection NCT06672055
A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease NCT07419828
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age NCT07300839
NAVIGATE NCT06609460
MARITIME-HF NCT07037459
BaxDuo-Pacific NCT06742723
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study NCT07620574
A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination NCT05911061
HERMES NCT05636176
A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) NCT06175494
BalanceD-HF NCT06307652
LANTERN NCT06702878
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010) NCT07071623
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China NCT07710872
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) NCT07165028
A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried NCT05667974
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) NCT07044297
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children NCT05543616
CAMBRIA-1 NCT05774951
ELEGANT NCT06492616
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 NCT05329220
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart NCT06935370
HEAL-MI NCT05881382
Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster. NCT05710783
Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine NCT05433285
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49 NCT07284654
COVID-19 NCT05993325
SUPERNOVA NCT05648110
MARITIME-1 NCT06858839
COVID-19 NCT05468736
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) NCT07654361
A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19 NCT05249829
TILIA NCT05624450
TRITON NCT04320342
REDEFINE 1 NCT05567796
RSVictory NCT05330975
A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months NCT06049927
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. NCT07629440
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION) NCT07684235
Nasal154PH3 NCT05522335
A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females NCT05584332
ATTAIN-1 NCT05869903
AZURE-LDL NCT07000123
A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination NCT05911048
MOVe-NOW NCT06667700
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine NCT06617715
Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive NCT05264506
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) NCT07116967
AURORA-1 NCT07743463
A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell) NCT07500207
Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells) NCT07028801
Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older NCT05683600
Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension NCT06492291
Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3 NCT05222425
A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A NCT05567783
A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids NCT05952856
DTaP NCT05091619
Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg NCT05569239
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) NCT07624305
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants NCT06345339
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations NCT06052267
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China NCT05662020
ACHIEVE-4 NCT05803421
REIMAGINE 2 NCT06065540
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People NCT06821061
A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19. NCT05246137
ROXI-INCLINE NCT07430956
ROCKET-ASCEND NCT05882877
A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older NCT06551181
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. NCT06268873
Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine NCT05642078
SURMOUNT-1 NCT07481747
BROADWAY NCT05142722
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) NCT05951725
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine NCT05284851
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight NCT07564414
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. NCT06372145
LILAC-TIMI 76 NCT05712200
Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old NCT05158777
Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells) NCT05969626
Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age NCT06694389
Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years NCT06314685
A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population NCT07103148
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) NCT06966700
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants NCT07573462
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older NCT07734649
PertaSafe NCT06798831
SCORPIO-PEP NCT05897541
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age NCT06824194
IOCYTE AMI-3 NCT04837001
TRIUMPH-1 NCT05929066
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease NCT06679140
ANGIODAPT NCT05952206
Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers NCT07791199
SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19 NCT05629962
REASSURE NCT05584657
CORAL NCT06397768
A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants NCT05447377
Actual Use Trial of Tadalafil 5 mg NCT06805513
EURELIA2 NCT05586971
A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants NCT05242432
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH NCT06528314
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 NCT07431281
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis NCT06550076
SCORPIO-HR NCT05305547
RELIEF NCT04384367
A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally NCT05098938
OAKTREE NCT05715528
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) NCT05878769
dal-GenE-2 NCT05918861
Eluminate-5 NCT07662109
Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks NCT06025695
New Generation mRNA Booster Vaccine Against Emerging VOCs NCT05580159
ROXI-APEX NCT07015905
ROXI-ASPEN NCT07213778
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis NCT07697456
ENLIGHTEN-1 NCT07321886
Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer NCT05780567
ROXI-PEAK NCT07697599
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer NCT06112379
ICONIC-HF NCT06929806
EvoPAR-PR01 NCT06120491
RIVER-AD NCT05492578
TETON-OLE NCT04905693
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age NCT06740630
Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria) NCT06087835
Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults NCT05188677
A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL NCT05421611
A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) NCT06708286
A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age NCT05436834
A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer NCT07441460
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022) NCT05239728
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine NCT07645924
A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines NCT05323461
COMET-HF NCT06736574
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis NCT06632444
Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants NCT05759520
Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging NCT06632912
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults NCT05827926
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy NCT07052903
NEBULA-1 NCT07701993
KALUMA NCT05842954
PROSPERO NCT05742802
FIBRONEER™-ON NCT06238622
ACHIEVE-3 NCT06045221
PIVOT-PO NCT06059846
ONWARD3 NCT06846541
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1) NCT05463731
CONFIDENCE NCT05254002
FREXALT NCT06141473
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis NCT06215716
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial NCT07112144
FRAmework-01 NCT07213804
Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential NCT06672016
A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy NCT06126640
ATTAIN-2 NCT05872620
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients NCT05899608
ROXI-CAT-II NCT07493304
A Study of JNJ-64281802 for the Prevention of Dengue Infection NCT05201794
A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) NCT05665595
Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053) NCT05314023
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis NCT06632457
MajesTEC-7 NCT05552222
Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants NCT06344065
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer NCT06712316
COVID-19 NCT05519839
Tranquillo 2 NCT06072183
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery NCT05608291
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis NCT07223138
AURORA-2 NCT07743450
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV NCT06413121
PROST-2 NCT05700591
Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 NCT05633433
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma NCT05352672
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above NCT05590403
Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females NCT05461573
ESTUARY NCT06407934
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) NCT06393374
Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older NCT06686654
Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa NCT05794230
Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older NCT05304351
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) NCT05633654
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers NCT05621655
COLOSSUS NCT07793409
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) NCT05508789
CAPTAIN-T2D NCT07296484
Up-AA NCT06012240
V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071) NCT05450705
BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient NCT05322707
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight NCT06143956
A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years NCT06131554
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia NCT05610280
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above NCT06389487
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults NCT07628049
MUIR-3 NCT06347133
MIRANDA NCT06040086
A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals NCT05472038
A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy NCT06830889
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) NCT06925737
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors NCT07070232
XePOHCAS NCT03176186
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults NCT05989048
A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE） NCT05295173
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer NCT07222566
STEP UP NCT05646706
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) NCT06653153
Adjuvant WIDER NCT05827081
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) NCT05667493
Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated NCT05433272
Intrepid NCT06468228
STELLAR-002 NCT05176483
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age NCT07365826
Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection NCT05109611
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) NCT06651281
FORCE2 NCT05292586
Tilrek NCT07783425
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria NCT07256392
JT001 (VV116) for the Treatment of COVID-19 NCT05582629
Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) NCT05568888
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults NCT06182124
A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid NCT06221072
A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study NCT05211947
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People NCT06683352
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) NCT06318169
AVANZAR NCT05687266
COVID-19 NCT05372588
ALLEGRO-100 NCT06873945
EvoPAR-PR05 NCT07711002
Step-Up HS NCT05889182
TENACITY NCT07361302
A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age NCT06864143
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) NCT06136650
OMAHA-003 NCT06136624
Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age. NCT05513053
A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB NCT07095855
ATO ACUTE NCT06241313
OLERO NCT05269004
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML NCT07007312
COMBINE 1 NCT05352815
ARNASA NCT05595642
Continuation Protocol for Obstructive Sleep Apnea (OSA) NCT06566820
KATALYST-AV NCT07001800
VAST-A NCT05139849
NILEAD NCT05143528
REMASTER NCT07225504
SUNRAY-01 NCT06119581
A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine NCT06207175
Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population NCT06049940
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis NCT06003426
TRIPLAR NCT06234345
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis NCT05587309
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) NCT06260722
ZENITH-2 NCT07221188
Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19 NCT05656443
Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine NCT07740733
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma NCT05827016
ALPINE 1 NCT06522997
ARTEMIDE-HCC01 NCT06921785
Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents NCT06128733
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age NCT07406360
A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19 NCT05506176
A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B. NCT07412236
ATTAIN-PAD NCT07223593
KLK2-comPAS NCT07164443
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011) NCT06136559
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) NCT06312176
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) NCT06430801
A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age NCT05839301
Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months NCT06399003
Eluminate-2 NCT07662213
HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2 NCT05787418
Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above NCT05664932
KaiNETIC-3 NCT07284979
Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults NCT07147400
Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above NCT07327398
Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell). NCT06654700
Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 NCT05580341
REDEFINE 2 NCT05394519
ROXI-ATLAS NCT07175428
Study to Evaluate GR1801's Efficacy and Safety NCT05846568
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents NCT07660198
UBRO PEDS OLE NCT05127954
ZENITH-1 NCT07221227
VIGILANT NCT07177339
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis NCT07286058
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) NCT06757634
Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age NCT06641180
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) NCT05321082
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) NCT05321069
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6) NCT05738486
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) NCT05629585
TITANIA NCT05158387
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) NCT05555732
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty NCT06825416
A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older NCT06744205
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC NCT06627647
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) NCT06692738
COPD NCT07363694
Phase III Study of TS-142 in Patients with Insomnia NCT05453136
TRIUMPH-2 NCT05929079
ASTER NCT05171049
eVOLVE-HNSCC NCT06129864
A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). NCT05886777
SunRISe-3 NCT05714202
Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age NCT05310084
OBERON NCT05166889
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma NCT06047080
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors NCT06445062
REFOCUS-ALZ NCT05026177
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors NCT05438329
TroFuse-033 NCT06952504
ENSURE-1 NCT05134441
A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder NCT07786454
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth NCT06648850
ROXI-CAT-I NCT07410117
ELARA NCT06491914
Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty NCT05558410
ABTECT - Maintenance NCT05535946
MagnetisMM-6 NCT05623020
Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults NCT05879107
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period NCT06108544
MARITIME-2 NCT06858878
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005) NCT07705607
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) NCT07654374
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma NCT07772921
AB02 NCT07221253
ENSURE-2 NCT05201638
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy NCT06628908
Optimum 2 NCT06778967
Pebblestone NCT06094010
SURPASS-IPF NCT07284602
TREVI-OC-01 NCT07218809
SAIL NCT07241520
EPCORE™FL-2 NCT06191744
ICONIC-CD NCT07196722
Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age NCT06975878
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) NCT05933577
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines NCT06671483
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension NCT06153693
Open-label Extension for Phase 3 Clinical Trials of Simufilam NCT05575076
A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer NCT06417008
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age NCT05496231
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension NCT05968430
Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy NCT05553366
ROSY-S NCT07691970
EXHALE-2 NCT05763121
Ubro Peds NCT05125302
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis NCT06025578
KANDELA-302 NCT07492641
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age NCT05501561
BAROLO NCT06957080
A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals NCT05997290
PACIFIC-9 NCT05221840
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) NCT06065748
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children NCT05546502
Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy NCT05617820
HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors NCT06336707
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) NCT06717347
A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris NCT07469228
Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes NCT05834868
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months NCT07505836
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months NCT07505823
STAR-221 NCT05568095
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder NCT05525637
CAPItello280 NCT05348577
ENLIGHTEN-2 NCT07282600
FourLight-3 NCT06760637
A Phase III Confirmatory Study of K-237 NCT05056883
A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above NCT05559476
Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age NCT05096208
ENVISION NCT05310071
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor NCT06221969
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) NCT07216703
REIMAGINE 5 NCT06534411
STAR-121 NCT05502237
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) NCT07549412
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) NCT06052059
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza NCT05596734
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients NCT06549595
Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults NCT06151288
SELECT-SLE NCT05843643
Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age NCT05630859
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2) NCT05156281
COURAGE NCT06299098
Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) NCT03630081
SMART NCT04938830
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) NCT07060807
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis NCT05862272
A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris NCT06733402
A Study of DB-1310 in Advanced/Metastatic Solid Tumors NCT05785741
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) NCT06841354
A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer NCT07679360
AMAZE 8 NCT07400107
BAIYUN NCT06471257
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1) NCT05147220
Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma NCT05710198
Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) NCT06087276
OrigAMI-2 NCT06662786
Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine NCT05249816
RELATIVITY1093 NCT06561386
RESTRAIN-SUI NCT07202884
Study to Assess the Safety and Effectiveness of NMRA-335140-501 NCT06029439
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. NCT07028853
TRIlogy-7 NCT07665450
ATLANTIS NCT05769777
COVID-19 NCT05925127
Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine NCT06678620
A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults NCT06382311
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer NCT07221357
A Study YL201 in Patients With Selected Advanced Solid Tumors NCT06057922
A Study of BL-M07D1 With or Without Pertuzumab Versus Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer NCT06891833
BRUNELLO NCT06571045
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue NCT06989437
Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older NCT06695117
Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older NCT06695130
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above NCT07204964
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) NCT07634471
MALBEC NCT07440225
TORRONTES NCT07496567
ReCOV NCT05084989
CORAL NCT07721545
To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults NCT05805826
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer NCT05216432
A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder NCT05593029
Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above NCT05856084
SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor NCT06350006
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840
A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension. NCT07708441
Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine NCT06181292
A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above NCT06361875
Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity NCT05579977
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants NCT06720038
A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma NCT07490301
AIRPHRODITE NCT06609239
Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration. NCT05142553
A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease NCT06547333
RAINFOL-01 NCT05579366
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19) NCT07712588
PIKALO-1 NCT05768139
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors NCT06703177
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors NCT05914116
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer NCT06161025
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer NCT07005102
Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid) NCT07600983
PanTumor-101 NCT06551142
A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older NCT07311148
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1) NCT05384626
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316) NCT06879145
LIVIGNO-4 NCT06236438
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer NCT07392892
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults NCT05266456
KANDLELIT-001 NCT05067283
A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer NCT07294534
A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19 NCT05197153
A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age NCT05630846
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors NCT06741644
A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2 NCT05911087
A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age NCT05084508
Immunogenicity and Safety of SYS6017 in the Participants Aged 40 Years and Above NCT07354659
A Study of ASP1002 in Adults for Treatment of Solid Tumors NCT05719558
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors NCT05150691
HS-20117 NCT06621563
TRECONY NCT07301736
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma NCT06841679
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older NCT07121192
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread NCT06324357
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over NCT06569823
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors NCT06963502
A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris NCT06063473
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004) NCT07614984
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors NCT06607185
ORIGIN EXTEND NCT06674577
Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants NCT06647407
TeLuRide-008 NCT07365319
Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial NCT06063057
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors NCT06792552
Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine NCT07291635
A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants NCT05082285
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure NCT07562087
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762
A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease NCT05182840
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation NCT06179160
A Trial to Evaluate the Effect of CD388/MK1406 on the Immunogenicity of Fluzone® HD Vaccine (CD388.SQ.1.08/MK-1406-007) NCT07300085
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder NCT06480383
DUET-CD NCT05242471
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older NCT07208461
A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia NCT05443724
Booster Study of COVID-19 Protein Subunit Recombinant Vaccine NCT05525208
CERTIS1 NCT05417594
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan NCT05005403
A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults NCT05960097
AIRCULES NCT06102005
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older NCT05624606
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older NCT05650554
A Study of ASP3082 in Adults With Advanced Solid Tumors NCT05382559
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064
Revive NCT05953480
FORAGER-1 NCT05614739
SOLARA NCT06706076
FLASH NCT05251259
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD NCT06981078
BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079
KARDIA-2 NCT05103332
Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) NCT06099990
Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1) NCT07711223
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age NCT05701800
Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate NCT06134648
A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals NCT06932523
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers NCT05356741
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults NCT06237049
MERANTI NCT06625060
Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey NCT05150496
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above. NCT07779408
MOONRAY-01 NCT06586515
NeoCOAST-2 NCT05061550
Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) NCT05142514
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo NCT06131372
QLS5132 Combination Therapy in Advanced Solid Tumors NCT07453394
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) NCT06991257
Clinical Trials of Quadrivalent Influenza Vaccine NCT06824519
FOG-001 in Locally Advanced or Metastatic Solid Tumors NCT05919264
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC NCT06162221
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors NCT06332170
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) NCT04988555
RENEW-COPD NCT07759245
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants NCT06524414
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations NCT06892522
FONTANA NCT05797168
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine NCT05238454
AURORAS-1 NCT06983743
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) NCT06703073
Navigator NCT07684820
Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers NCT06840119
preEMBER NCT07287098
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) NCT05947955
Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell) NCT05172193
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults NCT05875961
SYS6090 Combination Therapy in Advanced Lung Cancer NCT07472647
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011) NCT06890884
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors. NCT05867420
Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus NCT05669599
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations NCT06581432
Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older NCT05608005
DUET-UC NCT05242484
A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis. NCT07546214
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors NCT07349537
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors NCT07066657
A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults NCT05333289
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies NCT05131022
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor NCT05194982
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors NCT06475300
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors NCT05836324
Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age NCT07516418
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder NCT06701903
CYCAD-1 NCT06188520
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes NCT05822544
ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer NCT06825624
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older NCT05553301
Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older NCT06237296
Cycle-1-REF NCT06215911
A Study of IBI363 in Subjects With Advanced Malignancies NCT06468098
AIRLYMPUS NCT06676319
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors NCT05653882
Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). NCT06754384
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old NCT05375838
INVENT NCT06999603
MODIFY CSX NCT06279793
A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People NCT05227196
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors NCT05584670
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) NCT04929223
ALTITUDE-AD NCT06335173
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters NCT05137236
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine NCT06801509
Target CD NCT06548542
Umbriel NCT06932263
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants NCT07286370
A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight NCT06440980
A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients NCT06555068
H06_04TP NCT07320716
A Clinical Study of V540A in Healthy Female Participants (V540A-005) NCT07224477
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors NCT06589596
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above NCT06642558
PALOMA-2 NCT05498428
CKD-706 NCT07358156
Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine NCT07400003
TANGO NCT06029595
A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell) NCT05293548
Study of MHB088C for Patients With Advanced Solid Malignant Tumors NCT07102004
PANAIRAMA NCT07532265
A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults NCT05788237
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese NCT05616013
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes NCT05298254
Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma NCT05460767
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis NCT05646381
A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735
A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients. NCT07283367
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors NCT06384807
A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older NCT07128121
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes NCT05144984
Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults NCT07703956
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors NCT06771622
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors NCT06384352
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586
A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy Participants NCT06475729
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD NCT07016412
PROGRESS NCT06203002
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors NCT06400472
ZUPREME NCT06662539
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease NCT06926660
RESOLUTION-1 NCT05516758
A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism NCT05412979
ZYNERGY NCT07589686
A Study of ZG005 in Patients With Advanced Solid Tumors NCT06233292
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults NCT05703607
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer NCT07079631
A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants NCT07205796
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas NCT05279300
A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers NCT06577298
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) NCT07038343
COPERNICUS NCT06667076
Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV NCT05205083
Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac NCT05205096
PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months NCT07333352
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) NCT06196879
Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects. NCT05734040
A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis. NCT06673654
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors NCT07128303
A Study of HS-20110 in Participants With Advanced Solid Tumors NCT06892379
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) NCT07293351
A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors NCT07660432
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors NCT05458219
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors NCT05983432
Evaluation the Safety of hemay005 Tablets NCT06908642
A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine NCT06581575
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection NCT07367529
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease NCT06717698
MSP3-CRM-Vac4All/ Alhydrogel® Vaccine NCT05776017
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants NCT06690515
RENEW-Op-1 NCT07420283
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) NCT06843447
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers NCT07226843
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas NCT06090539
Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults NCT07304518
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) NCT05162586
A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes NCT05333835
GARDEN TIMI 74 NCT05492500
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) NCT05489211
To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis NCT06061471
A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants NCT05644353
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) NCT05939648
A Study of HS-20124 in Patients with Advanced Solid Tumors NCT06763159
A Study of Mirikizumab Solution (LY3074828) in Healthy Participants NCT07446101
A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA NCT07140523
A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis NCT06700499
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB) NCT07048262
Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine NCT06703203
Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) NCT05770180
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD NCT07423533
Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors NCT06960395
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age NCT06702449
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations NCT06835569
ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. NCT06699576
A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects NCT07181694
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors NCT07256782
A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors NCT07241936
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease NCT07128628
Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D) NCT05731544
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation NCT05410145
HARMONIZE NCT06814145
MICA NCT05117476
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors NCT06764771
TIDE-asthma NCT05421598
A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir NCT05567952
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors NCT06877650
ELEVATE NCT05563220
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors NCT07094113
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors NCT06120283
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults NCT06742281
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine NCT06848075
A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor. NCT06305637
Study of AVZO-021 in Patients With Advanced Solid Tumors NCT05867251
SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC NCT06989671
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors NCT07287995
An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease NCT05543252
PURSUIT NCT06173570
Next Generation Rocklatan NCT06441643
A Study of YL242 in Subjects With Advanced Solid Tumors NCT07197827
OMNIRAY NCT07114601
Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants NCT06790290
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies NCT07220616
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) NCT06041269
A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) NCT05122650
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184
ASCEND-QW NCT07477704
BALANCE NCT07519395
Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years NCT07300644
Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People NCT05352867
Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old. NCT06305104
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases NCT05948813
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis. NCT06899217
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors NCT06618287
Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma NCT06021678
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity NCT06037252
A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors NCT07169994
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors NCT06697197
A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis NCT07364448
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors NCT06619587
Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid Tumors NCT06775236
Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors NCT05153096
Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster NCT05463354
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) NCT06660173
LUMUS NCT05966480
Soundtrack-E NCT06564038
SOLSTICE NCT06579105
Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose NCT07422285
Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose. NCT07545226
A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways NCT06741657
A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis NCT07330934
A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer NCT05353361
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults NCT06680128
SCALA NCT07725939
A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) NCT07417189
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine NCT05239806
A Study of DS-3939a in Participants With Solid Tumors NCT07739966
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC NCT06754930
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer NCT05635708
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years NCT05329051
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight NCT07589608
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors NCT07268040
A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors NCT06895928
Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine NCT05276206
Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell) NCT05109598
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD NCT06828887
EDGE-Lung NCT05676931
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) NCT05099172
FLORENZA NCT07059845
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors NCT05958121
NAVIGATE-2 NCT07225959
ProvONE NCT06134232
SAIVE NCT05305560
SNV1521 in Participants With Advanced Solid Tumors NCT06220864
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers NCT05910827
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer NCT05365581
A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants NCT05515601
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR) NCT06966479
A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors NCT05170958
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC NCT07645222
REZOLVE-AD NCT06136741
Study of XB010 in Subjects With Solid Tumors NCT06545331
A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema NCT05151731
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors NCT06427941
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old NCT05585632
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors NCT07730021
A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors NCT05518045
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity NCT06373146
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults NCT07290036
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors NCT06625775
A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential Hypertension NCT07700875
A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia NCT05227703
Efficacy and Safety of ALT-801 in the Treatment of Obesity NCT05295875
A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04) NCT05845814
AndroMETa-CRC NCT06820463
STREAM-AD NCT05131477
Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older NCT06604767
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors NCT07483554
A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants NCT05412030
Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older NCT06118151
THAMES NCT06850922
PK similarity NCT07543471
CurbMF NCT07529405
RSV OA=ADJ-023 NCT05921903
A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia NCT05227690
Clinical Trial of PCV24 in Adults Aged ≥18 Years NCT07543198
Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years NCT06583031
Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio NCT06732804
A Research Study Looking at New Protein-based Tablets in Healthy Male Participants NCT05129891
COVID-19 NCT05112848
Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People NCT05541861
A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris. NCT06673641
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer NCT06941142
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis NCT05832151
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) NCT05877547
A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008) NCT05261126
CRESCENDO NCT05492877
Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients NCT05933031
A Study to Learn About How a New Pneumococcal Vaccine Works in Adults NCT07086677
AVZO-023-1001 NCT06998407
DeLLphi-311 NCT07037758
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare NCT07145229
Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors. NCT06682611
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) NCT05540327
ASPIRE NCT06588686
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies NCT07024784
A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors NCT06008054
A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® NCT05332730
KARDIA-3 NCT06272487
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) NCT06225596
A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants NCT05618808
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 NCT04879329
Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes NCT07521631
First Time in Human Study of Long Acting VH4524184 Formulations NCT06310551
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) NCT06797635
Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults NCT06861101
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors NCT07397338
A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B NCT06425341
A Phase Ib/II Clinical Study of LBL-024 Combination Therapy in Patients With Metastatic Colorectal Carcinoma NCT07791758
A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults. NCT07280858
Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children NCT05116241
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors NCT06115642
A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy NCT06619847
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes NCT06603571
PROGRESS-AD NCT06079190
START-001 NCT05592626
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors NCT07094204
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors. NCT06015048
SYNERGY-101 NCT05098132
A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia NCT07550387
ARC-20 NCT05536141
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors NCT07029399
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors NCT05533697
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) NCT06863272
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine NCT05238441
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors NCT06730750
A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors NCT04996121
B-Sure NCT04954859
HORIZON NCT07621237
Mintaka NCT07282574
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes NCT07685808
Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors NCT06446388
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) NCT05118789
ARGiNAUT NCT07652658
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia NCT06179108
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) NCT05824975
A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003) NCT05816252
CEC-013/CEL NCT07298343
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer NCT06095089
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) NCT07193511
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight NCT06326060
ELENA NCT05560646
SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty NCT05752461
A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa NCT06046729
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer NCT05565378
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors NCT06241456
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma NCT07102901
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma NCT05548296
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors NCT06594874
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) NCT07589595
A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS) NCT07503873
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer NCT06343402
Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors NCT06947291
Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer NCT06222879
TOPAS-MSA NCT06568237
A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations NCT07313761
A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer NCT07669779
Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations NCT07226778
A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors NCT07749703
Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes NCT07387003
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations NCT06043817
Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria NCT03503058
A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors NCT07767474
An Efficacy and Safety Study of LTG-001 Following Abdominoplasty NCT07102459
A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma NCT06049290
Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV) NCT05435027
A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C） NCT07368608
A Study of GZR18 Injection in Obese/Overweight Patients NCT06256562
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors NCT06561685
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis NCT05995964
SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors NCT07022002
Study of HS-10517 in Chinese Adult Participants NCT05779579
The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia NCT07362355
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer NCT06179069
AJAX NCT06020014
JUNIPER NCT05536414
A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants NCT05632211
CARDINALS NCT05349721
Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa. NCT06722664
RIVER-ASTHMA NCT06033833
Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC NCT05272865
PRIMROSE NCT06130553
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment NCT06105632
TAILOR NCT05963074
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia NCT05091424
A Study in Patients With Advanced Cancers NCT05320588
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 NCT05557045
A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF) NCT05592275
A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects NCT07300189
EDGE-Gastric NCT05329766
SKB118 Injection in Advanced Solid Tumors NCT07586943
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors NCT07477743
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants NCT07214766
To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia NCT05763550
A Study of MK-7240 in Healthy Participants (MK-7240-009) NCT07405177
Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route NCT06126042
Study of EVO756 in Adults With Migraine NCT07616128
Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage NCT06968481
To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years NCT06756269
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. NCT06393738
MTAPESTRY 101 NCT05094336
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer NCT07381829
MOVE-IT NCT05621811
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002) NCT06780137
PLATINUM NCT05750628
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors NCT07537881
ATTRiumph NCT07608354
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS) NCT07222189
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC NCT06567743
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 NCT06084481
A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults NCT05446740
A Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects NCT05917782
A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer NCT05482568
MIRO-CKD NCT06350123
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD NCT06659445
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis NCT07284459
To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects NCT05108259
To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus NCT06481085
A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma NCT06153238
BENEFIT-PDT NCT05090657
Phase I PK Comparison of HLX05 vs. Erbitux® in Healthy Chinese Males: Safety, Immunogenicity, and Pharmacokinetics NCT06980454
SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors NCT05631262
A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer NCT07711184
A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. NCT05878691
A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] NCT05565742
A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults NCT07083739
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors NCT05785754
IL Believe NCT05081609
Illuminate1 NCT07494305
KRAScendo 170 NCT05789082
LuCa-MERIT-1 NCT05142189
MorningSun NCT05207670
Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty NCT06963320
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis NCT06097260
Safety and Efficacy of IBI389 Single Agent, and in Combination With Sintilimab, in Patients With Advanced Malignancies NCT05164458
Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine NCT05576623
Study Exploring the Supportive Effect of Acarbose in Weight Management NCT05934110
Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. NCT07396337
A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease NCT07418736
ELIMINATE NCT05488340
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma NCT06376045
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments NCT05137054
REDUCO NCT06244316
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 NCT06062420
COSMIC NCT05280717
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) NCT07133633
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder NCT06846320
A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity NCT06226090
MARS-17 NCT05838742
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis NCT06280391
A Study of BG-C477 in Participants With Advanced Solid Tumors NCT06596473
A Study to Learn About a Vaccine Against E Coli in Healthy Adults NCT07122986
ALLOHA NCT05473910
Celestial-1 NCT06466486
DENALI NCT05128825
Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine NCT05092386
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) NCT06833073
A Study of Modified mRNA Vaccines in Healthy Adults NCT05397223
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder NCT06817356
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors NCT06233942
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis NCT06257537
To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects NCT05413161
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women NCT04766086
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis NCT06926582
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) NCT05811351
A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis NCT05153148
COCOON NCT06120140
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease NCT05593575
HIMALAYA NCT05237284
A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years NCT06106581
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease NCT06538116
A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects NCT06159101
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids NCT05348200
A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism NCT05712421
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors NCT06952010
A Study of ZT002 Injection With Subjects With Overweight or Obesity NCT07020884
Cycle-2-PEF NCT06215586
GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease NCT05686551
A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin NCT06112808
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy NCT07021963
A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers NCT07233850
A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour NCT06915142
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke NCT07754825
A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC NCT06844474
A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects NCT05968508
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes NCT07668388
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer NCT05818683
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer NCT07229729
A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects NCT05188378
A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease NCT07349524
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years NCT05345873
A Study to Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 Subcutaneously (SC) Compared to Actemra® in Healthy Male Participants NCT06262477
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) NCT07154290
abatacept NCT06929039
ATMOS NCT07720375
BXOS110 Injection in the Treatment of Acute Ischaemic Stroke NCT06322394
Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis NCT07398859
EDITOR NCT06434818
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke NCT05686642
Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China NCT05682599
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy NCT06619860
Extension Study of Infigratinib in Children With Achondroplasia (ACH) NCT05145010
FIT-001 NCT06026410
GZBF NCT07467447
Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV) NCT05323435
KPCXM18 NCT07279493
Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine NCT05542693
Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli) NCT06314880
Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, Lozenges NCT06843018
Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections. NCT07420985
Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA) NCT05236842
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer NCT06787612
A Phase II Study of SKB571 in Patients With Lung Cancer NCT07230405
A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection NCT07411755
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer NCT07206225
MARIPOSA NCT05071612
Phase I Clinical Study of LNF2105 in Patients With Advanced Solid Tumors NCT07661797
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer NCT05775159
Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors NCT06724016
Study of INCB123667 in Subjects With Advanced Solid Tumors NCT05238922
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors NCT05954312
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms NCT06034002
RELIEVE UCCD NCT05499130
BiRCh NCT06013241
Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure NCT06669169
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC NCT06868732
Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors NCT05599984
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease NCT05785624
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen NCT05769608
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus NCT07282743
GYMINDA NCT06965413
Senaparib in mCRPC Patients With Homologous Recombination Repair Gene Alterations After Docetaxel Treatment NCT04822961
A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors NCT05614102
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis NCT06559150
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma NCT05259839
B-UNITED NCT06537414
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) NCT07195682
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis NCT07599813
A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors NCT07448922
A Study of V132 in Healthy Older Participants (V132-001) NCT07712575
A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder NCT06796868
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors NCT06004245
Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors NCT05198505
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab NCT06107413
Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis NCT06391164
A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19 NCT05981846
DAZALS NCT05407324
LIBRA NCT07098338
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors NCT06167317
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study) NCT06789913
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study NCT05934331
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors NCT05489237
Phase II Study of THDBH120 Injection in Overweight or Obese Subjects NCT07036601
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV NCT05904470
A Study of HS-20094 in Patients With T2DM NCT06901648
Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects NCT06688123
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer NCT06328738
MM NCT04960579
Study of ORIC-944 in Patients With Metastatic Prostate Cancer NCT05413421
ALLSTAR NCT07791043
A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus NCT06256549
A Study of PHST001 in Advanced Solid Tumors NCT06840886
A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults NCT05184062
INTerpath-004 NCT06307431
Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer NCT05014815
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) NCT05519449
Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery NCT06168799
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality NCT06496490
A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies NCT05753722
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes NCT07415954
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) NCT05869955
A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors NCT05508620
A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age. NCT06850051
ANCHOR-POC NCT07271186
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease NCT06409130
QR052107B Tablets in Patients With Subacute Cough of Phase Ⅱ Study NCT06920836
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers NCT06906341
Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke NCT06202378
SOUNDTRACK-B NCT06526793
TLN-372 in Advanced KRAS Mutant Solid Tumors NCT07204340
A Randomized, Single Intravenous Dose, Parallel Phase I Clinical Study to Compare the Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX05 Vs. Erbitux® (Cetuximab) in Healthy Adult Male Chinese Subjects NCT06309043
A Research Study Looking Into Blood Levels of Three Different Formulations of the Study Medicine Ziltivekimab NCT05721989
A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants NCT06144697
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. NCT05355701
HD-MAP NCT06417853
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies NCT06656494
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. NCT07470853
A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants NCT05784402
A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors NCT05125523
A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult Participants NCT06937619
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers NCT06663319
A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants NCT07007091
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia NCT05768932
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine NCT07203755
PIKASSO-01 NCT05307705
SIM0610-101 NCT07348211
A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With Advanced Solid Tumors NCT07753590
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma NCT07477587
HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion NCT07699757
A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva NCT05299073
A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers NCT06488521
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers NCT05527184
A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors NCT05781386
An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab NCT06908577
Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors NCT06963814
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001) NCT07247110
A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors NCT05194072
A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470
QTX3034 in Patients With KRAS G12D Mutation NCT06227377
Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings NCT07169409
A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects NCT06549959
A Study of SKB315 in Patients With Advanced Solid Tumors NCT05367635
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma NCT07176650
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors NCT06234397
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease NCT06308978
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms NCT06150157
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer NCT05683418
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer NCT06638307
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes NCT06267274
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma NCT06768489
A Study of LY4175408 in Participants With Advanced Cancer NCT07046923
A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors NCT06797336
A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants NCT06268860
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants NCT07226817
A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients NCT05198817
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors NCT06480552
Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older NCT06678607
QTX3046 in Patients With KRAS G12D Mutations NCT06428500
Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310 NCT05702450
Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age NCT07071558
VXB251-001 NCT07295028
A Trial to Assess the Pharmacokinetic Similarity Between CHS-1420 40 mg/0.4 mL and HUMIRA® (Adalimumab) 40 mg/0.4 mL in Healthy Chinese Adult Participants Under Fasting Conditions NCT07147257
QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations NCT06715124
A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending Doses NCT07063342
A Study to Learn About Whether BAY H006689 Causes an Allergic Reaction When Applied as a Topical Gel in Healthy Participants NCT06415019
Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects NCT06171048
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors NCT06997029
A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity NCT07597018
Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above NCT05408312
A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour NCT06383871
Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older NCT05426174
A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. NCT05320874
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC) NCT06858813
Solid Tumors NCT07265921
A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Administration With Prefilled Syringes in Healthy Adult Participants NCT06571266
A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants NCT06438263
A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects NCT07452692
Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years NCT06675032
A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults NCT06371534
A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression NCT07686445
Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor NCT06998173
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults NCT07464314
Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® NCT06310824
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer NCT05504213
A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants NCT05089019
Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban, or Aspirin Plus REGN9933, or Aspirin Plus REGN7508 in Healthy Adult Participants NCT06444178
Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants NCT05166421
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers NCT06717269
A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus NCT07606521
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors NCT06804824
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors NCT07241039
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) NCT05464030
DeLLphi-308 NCT06598306
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies NCT06577987
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors NCT06545942
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer NCT07278336
Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers NCT05735496
Study of INCA036978 in Participants With Myeloproliferative Neoplasms NCT07441694
Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects NCT07200986
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors NCT05981703
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors NCT07043751
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors NCT05787587
Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects NCT04711343
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection NCT05378737
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants NCT05418868
A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants NCT07525544
Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer NCT05293964
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors NCT06544655
A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years NCT06573281
Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants NCT07258745
A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants NCT07146750
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years NCT07413666
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002) NCT07300267
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors NCT07300150
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma NCT05650632
Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients NCT06139536
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors NCT05907980
AVT03 With Prolia in Healthy Male Subjects NCT05126784
A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy NCT06211751
A Phase I Study of 9MW4113 Injection Versus Dupixent® NCT07791342
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age NCT07082829
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer NCT07570979
AVT03 With Xgeva in Healthy Male Subjects NCT05876949
Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis NCT06175338
Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects NCT05576454
Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers NCT05245669
A Study of LY3541105 in Healthy and Overweight Participants NCT05380323
A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors NCT05868876
A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge NCT05681845
PK, PD, Safety & Immunogenicity of ADL-018 Lyo in Healthy Adult Subjects NCT05564611
A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers NCT07738991
A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors NCT07380334
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies NCT06759649
A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis NCT07351968
A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection NCT05203289
A Study of AK146D1 for Injection in Advanced Solid Tumors NCT07067567
A Study of MHB118C Injection in Patients With Advanced Solid Tumors NCT07045454
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors. NCT05877924
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer NCT07227168
A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors NCT07123129
BOREALIS-1 NCT07021898
JMT106 Injection in the Treatment of Advanced Solid Tumors NCT07275073
PIKture-01 NCT06239467
Sustained Acoustic Medicine for Osteoarthritis Pain NCT05254574
To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab) NCT06687928
A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent® NCT06614907
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML NCT05641259
A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects NCT07334496
HER2 NCT05650879
PAnTHA NCT06217822
Study to Evaluate the Relative Bioavailability of Two Risankizumab Drug Product Presentations in Healthy Volunteers. NCT05567029
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies NCT05453903
A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent Pan-Salmonella Vaccine With and Without Alum in Healthy Young Adults NCT07663032
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer NCT07604571
A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects NCT07560033
A Study of DS5361b in Participants With Advanced Solid Tumors NCT07182591
Study of QLS5308 in Patients With Advanced Solid Tumors NCT07462442
Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe NCT05405985
A Study of Olomorasib (LY3537982) in Healthy Japanese Participants NCT07124013
A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants NCT07312851
The Study of ICP-248 in Patients With Mature B-cell Malignancies NCT05728658
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) NCT05155332
Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors NCT05213767
DENARIUS NCT05323708
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer NCT05508906
A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity NCT06916065
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma NCT06153251
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma NCT06121843
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months NCT05743881
A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions NCT06487416
GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors. NCT07407504
SW-682 in Advanced Solid Tumors NCT06251310
This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS). NCT06738277
Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old NCT05477186
First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) NCT05361395
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects NCT05384262
A Study of AK129 in Patients With Advanced Malignant Tumors NCT05645276
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection NCT05620017
Study of GS-4528 in Adults With Solid Tumors NCT05840224
A Clinical Study Comparing the Bioequivalence of IBI3027 and DUPIXENT®(Dupilumab) in Healthy Chinese Volunteers NCT07502534
A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine NCT07495202
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) NCT06056050
A Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of RPH-035 and Ocrevus® in Patients With Relapsing-remitting or Secondary Progressive Multiple Sclerosis With Exacerbations NCT07597668
A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI NCT07543744
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease NCT06375993
A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection NCT07694557
A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers NCT06494345
A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors NCT06970795
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies NCT07368478
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC) NCT07416552
A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants NCT07635095
Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab NCT05339100
Clinical Trial of PCV24 in Infants Aged 2-23 Months NCT06800261
Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers NCT05192512
Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors NCT05489276
Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults NCT05777109
Comparison of Pharmacokinetics and Safety of HS627(2 Specifications) Versus PERJETA With a Single Injection NCT05323981
GenSci143 in Participants With Advanced Solid Tumors NCT07252414
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors NCT05239143
Pharmacokinetic, Immunogenicity, and Safety Evaluation of Pegfilgrastim TPI-120 in Healthy Adults NCT07416955
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors NCT06784193
Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors NCT06823609
Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above NCT07285265
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors NCT07261631
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas NCT07082803
A Bioequivalence Study of Two Different Dosage Form of Genakumab NCT06451848
A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects NCT07327697
A Study on How NNC0174-1213 Works in People With Overweight or Obesity. NCT06719011
A Study of HS-20089 in Patients With Advanced Solid Tumors NCT05263479
ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors NCT05276609
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors NCT06108050
SIRACUSA NCT05383352
A Phase 1 Study of FZ008-145 in Healthy Subjects. NCT06685809
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer NCT07310420
Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis NCT07207954
A Study of Subcutaneous Gefurulimab Using Prefilled Syringe Versus Autoinjector in Healthy Adult Participants NCT06208488
Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018 NCT05228613
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors NCT07160335
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors NCT07518043
A Study to Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of SB35 (Proposed Ixekizumab Biosimilar) to Taltz in Healthy Participants NCT07789964
A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy Participants NCT05981976
The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors NCT05836948
A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated NCT06745297
A Study of QLM2011 in Subjects With Advanced Solid Tumors NCT06925659
A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults NCT05995249
A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects NCT05679258
Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation NCT06015568
To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects NCT07054970
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT06001788
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome NCT06501196
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors NCT07251166
Clinical Trial of PCV24 in Adults NCT06474377
A Relative Bioavailability Study of LY3209590 in Healthy Participants NCT05615532
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults NCT06173011
A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain NCT07377721
A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH NCT05945537
A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies NCT06820268
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV NCT06724640
A Study to Evaluate the Bioequivalence of Ruxolitinib Extended Release (XR) Tablets With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants NCT06555081
ON-5001 NCT06022029
Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects NCT07150962
EGRET NCT05647122
A Phase I Study of CFT8919 in Patients With Advanced NSCLC NCT06641609
A Study of BR111 in Patients With Advanced Malignancies NCT06937957
Bioequivalence Study of Tafolecimab Injections in Chinese Healthy Male Volunteers NCT05792917
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma NCT05651932
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors NCT05581004
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis NCT06154447
A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies NCT06038058
A Study of How CagriSema Works on Appetite in People With Excess Body Weight NCT06267092
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors NCT05270213
JADE NCT07484074
A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy NCT06268613
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors NCT06772415
A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors NCT06618651
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers NCT06562192
Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019) NCT05818124
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD. NCT07116915
A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant) NCT07349017
A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants NCT07180862
A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors NCT06328673
A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects NCT07264335
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants NCT05533801
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms NCT05936359
A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants NCT06058390
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors NCT07540572
Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets NCT06801418
Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine NCT06621654
DeLLphi-313 NCT07531095
Evaluate LAE102 in Healthy and Overweight/Obese Subjects NCT06493084
First In Human Study of CX-2051 in Advanced Solid Tumors NCT06265688
First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults NCT06194318
Phase I Trial of Envafolimab for Healthy Male Subjects NCT05849311
Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults NCT06843317
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations NCT05364073
Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration NCT07554222
A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants NCT06345755
Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers NCT05370950
Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above NCT05829356
A Study of AL8326 in Non-Small Cell Lung Cancer NCT06794957
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma NCT06600321
A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants NCT05362045
A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Participations NCT07619001
Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes NCT06403761
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors NCT05381909
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) NCT06655246
HS-10502 NCT06769425
STARLYS NCT07610941
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD NCT07116889
A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults NCT05189717
Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors NCT05479812
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors NCT07660055
A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms NCT06651229
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure NCT06746064
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors NCT06657144
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7) NCT04970901
A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity NCT07717814
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors NCT06532565
A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624 NCT05378893
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer NCT06115902
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia NCT06315283
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet NCT05429593
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants NCT07723833
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC NCT06186414
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors NCT05277051
LEUCETTA NCT06206824
A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors NCT07730190
A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System NCT05275010
Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia NCT05245539
A Clinical Study With Adalimumab Biosimilar NCT06291948
A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects. NCT06929052
A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers NCT07299955
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors NCT07020117
A Study of Idazoxan in Healthy Participants NCT05727189
A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors NCT07787520
A Study of SKB518 in Patients With Advanced Solid Tumors NCT06428331
A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants NCT06375512
A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors NCT06907628
Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers NCT06188624
Clinical Trial of TQB3002 in Patients With Advanced Cancers NCT06662760
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors. NCT05547321
FANTASY NCT05121246
First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors NCT05828459
Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults NCT06334393
Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine NCT07374510
Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202 With or Without ASK120067 NCT05306132
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers NCT05245838
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis NCT07558668
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 NCT07218003
A Study of LY3841136 in Healthy and Overweight Participants NCT05295940
DehydraTECH NCT06648031
Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives NCT07792408
A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets NCT05327491
A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027) NCT06930664
A Study to Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healthy Subjects NCT05974969
INVOKE NCT06789172
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects. NCT07153146
A Study of BGM0504 Tablets in Healthy Chinese Subjects NCT07566572
A Study of LY4268989 (MORF-057) in Healthy Participants NCT06964776
A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults NCT06556147
A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors NCT05114915
Bioequivalence Study of BGM0504 Injection NCT07382908
Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants NCT05599802
Clinical Trials of IBI3035 in Healthy Subjects NCT07591519
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434 NCT05484206
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation NCT05504278
EXTEND-101 NCT07617194
RAMBO NCT07010432
SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a) NCT07745114
STRIKE-001 NCT07103018

Drugs

Companies

AstraZeneca
Eli Lilly and Company
Merck Sharp & Dohme LLC
GlaxoSmithKline
Pfizer
AbbVie
Novo Nordisk A/S
Sanofi
Amgen
Janssen Research & Development, LLC
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Sanofi Pasteur, a Sanofi Company
Boehringer Ingelheim
Hoffmann-La Roche
ModernaTX, Inc.
Novartis Pharmaceuticals
BioNTech SE
Jiangsu HengRui Medicine Co., Ltd.
Shanghai Henlius Biotech
Hansoh BioMedical R&D Company
Innovent Biologics (Suzhou) Co. Ltd.
Qilu Pharmaceutical Co., Ltd.
Shandong Suncadia Medicine Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Bayer
Bio-Thera Solutions
CanSino Biologics Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Gilead Sciences
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Sinocelltech Ltd.
Sinovac Life Sciences Co., Ltd.
Sun Pharmaceutical Industries, Inc.
Vertex Pharmaceuticals Incorporated
Akeso
BeOne Medicines
Incyte Corporation
Jiangsu Simcere Pharmaceutical Co., Ltd.
MAXVAX Biotechnology Limited Liability Company
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Changchun GeneScience Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Daiichi Sankyo
Genentech, Inc.
Novavax
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sinovac Biotech Co., Ltd
Takeda
Alnylam Pharmaceuticals
Changchun BCHT Biotechnology Co.
Chiesi Farmaceutici S.p.A.
Exelixis
Hipra Scientific, S.L.U
Kashiv BioSciences, LLC
Kura Oncology, Inc.
National Vaccine and Serum Institute, China
PT Bio Farma
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai JMT-Bio Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Teva Branded Pharmaceutical Products R&D, Inc.
Vaxcyte, Inc.
Vir Biotechnology, Inc.
WestVac Biopharma Co., Ltd.
AIM Vaccine Co., Ltd.
Alvotech Swiss AG
Astellas Pharma Global Development, Inc.
Avenzo Therapeutics, Inc.
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
BioRay Pharmaceutical Co., Ltd.
Celltrion
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
CSPC Megalith Biopharmaceutical Co.,Ltd.
DualityBio Inc.
EyeBiotech Ltd.
Guangzhou Patronus Biotech Co., Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
Reinovax Biologics Co., LTD
Revolution Medicines, Inc.
Seagen, a wholly owned subsidiary of Pfizer
Serum Institute of India Pvt. Ltd.
Shanghai Institute Of Biological Products
UCB Biopharma SRL
ViiV Healthcare
Arcus Biosciences, Inc.
BeiGene
Biocad
Biocon Biologics UK Ltd
Biogen
China National Biotec Group Company Limited
EMD Serono Research & Development Institute, Inc.
Gan & Lee Pharmaceuticals.
Gan and Lee Pharmaceuticals, USA
HC Biopharma Inc.
Insud Pharma
Jazz Pharmaceuticals
Jiangsu Rec-Biotechnology Co., Ltd.
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Mineralys Therapeutics Inc.
Nanjing Leads Biolabs Co.,Ltd
Otsuka Pharmaceutical Development & Commercialization, Inc.
Quanta Therapeutics
Seqirus
Shanghai Bovax Biotechnology Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd
Shenzhen Shenxin Biotechnology Co., Ltd
Shionogi
Stemline Therapeutics, Inc.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Upstream Bio Inc.
Vividion Therapeutics, Inc.
Akero Therapeutics, Inc
Alumis Inc
Anthos Therapeutics, Inc.
AO GENERIUM
Apnimed
ArriVent BioPharma, Inc.
Arvinas Inc.
Ascletis Pharma (China) Co., Limited
Astellas Pharma Inc
Atea Pharmaceuticals, Inc.
Bavarian Nordic
Beijing Continent Pharmaceutical Co, Ltd.
Beijing Health Guard Biotechnology, Inc
Beijing InnoCare Pharma Tech Co., Ltd.
Beijing Suncadia Pharmaceuticals Co., Ltd
Betta Pharmaceuticals Co., Ltd.
BlossomHill Therapeutics
BrightGene Bio-Medical Technology Co., Ltd.
Cardurion Pharmaceuticals, Inc.
Cassava Sciences, Inc.
Cellid Co., Ltd.
Centessa Pharmaceuticals (UK) Limited
Chong Kun Dang Pharmaceutical
CinDome Pharma, Inc.
Clover Biopharmaceuticals AUS Pty
Corcept Therapeutics
CSL Behring
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
CStone Pharmaceuticals
Dr. Falk Pharma GmbH
Dynavax Technologies Corporation
Enliven Therapeutics
Erasca, Inc.
Eurofarma Laboratorios S.A.
Fate Therapeutics
Fujian Shengdi Pharmaceutical Co., Ltd.
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Genmab
Guangdong Hengrui Pharmaceutical Co., Ltd
Haisco Pharmaceutical Group Co., Ltd.
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Hanmi Pharmaceutical Company Limited
Hudson Biotech
IDEAYA Biosciences
Immunic AG
Intra-Cellular Therapies, Inc.
Ionis Pharmaceuticals, Inc.
Ipsen
K36 Therapeutics, Inc.
Kallyope Inc.
Keymed Biosciences Co.Ltd
Laekna Limited
LB Pharmaceuticals Inc.
Livzon Pharmaceutical Group Inc.
mAbxience Research S.L.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
NewAmsterdam Pharma
Ningbo Rongan Biological Pharmaceutical Co., Ltd.
NovaRock Biotherapeutics, Ltd
Nurix Therapeutics, Inc.
Nuvalent Inc.
Olema Pharmaceuticals, Inc.
Ondine Biomedical Inc.
Organon and Co
OrsoBio, Inc
Osivax
PAQ Therapeutics, Inc.
Poseida Therapeutics, Inc.
R-Pharm
Relay Therapeutics, Inc.
RemeGen Co., Ltd.
Samsung Bioepis Co., Ltd.
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Shanghai Hansoh Biomedical Co., Ltd
Shanghai Hutchison Pharmaceuticals Limited
Shanghai JunTop Biosciences Co., LTD
Shenyang Sunshine Pharmaceutical Co., LTD.
SK Bioscience Co., Ltd.
Stemirna Therapeutics
Tonghua Dongbao Pharmaceutical Co.,Ltd
Treeline Biosciences, Inc.
Valenta Pharm JSC
Valneva Austria GmbH
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Vigonvita Life Sciences
Wuhan Createrna Science and Technology Co., Ltd
Xuanzhu Biopharmaceutical Co., Ltd.
ZetrOZ, Inc.
3D Medicines (Sichuan) Co., Ltd.
89bio, Inc.
Abbisko Therapeutics Co, Ltd
Abivax S.A.
Acrivon Therapeutics
Acumen Pharmaceuticals
ADC Therapeutics S.A.
Adicet Therapeutics
Adlai Nortye Biopharma Co., Ltd.
Advenchen Laboratories, LLC
Aktis Oncology, Inc.
Alcon Research
Alexion Pharmaceuticals, Inc.
Alterome Therapeutics, Inc.
Altimmune, Inc.
AM-Pharma
Amneal Pharmaceuticals, LLC
AnaptysBio, Inc.
Angde Biotech Pharmaceutical Co., Ltd.
Anhui Hemay Pharmaceutical Co., Ltd
Antares Therapeutics, Inc
Apollo Therapeutics Ltd
Applied Biology, Inc.
Aramis Biotechnologies Inc.
Areteia Therapeutics
Arrowhead Pharmaceuticals
Ascendis Pharma Oncology Division A/S
Asher Biotherapeutics, Inc.
AskGene Pharma, Inc.
Astria Therapeutics, Inc.
Atom Therapeutics Co., Ltd
AusperBio Therapeutics Inc.
Azidus Brasil
Bausch & Lomb Incorporated
BeBetter Med Inc
Beijing Biostar Pharmaceuticals Co., Ltd.
Beijing Greatway Pharmaceutical Technology Co.,Ltd.
Beijing Minhai Biotechnology Co., Ltd
Beijing QL Biopharmaceutical Co.,Ltd
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Bharat Biotech International Limited
BicycleTx Limited
BioAegis Therapeutics Inc.
Biocells (Beijing) Biotech Co.,Ltd
Biocity Biopharmaceutics Co., Ltd.
Biofabri, S.L
Biohaven Therapeutics Ltd.
Biomad AS
Biomea Fusion Inc.
BiOneCure Therapeutics Inc.
BioNet-Asia Co., Ltd.
Boulder Care
Braintree Laboratories
Celcuity Inc
Celldex Therapeutics
Cerevel Therapeutics, LLC
CG Oncology, Inc.
Changzhou Qianhong Bio-pharma Co., Ltd.
Chengdu CoenBiotech Co., Ltd
Chugai Pharmaceutical
Cipla Ltd.
Circle Pharma
Citius Pharmaceuticals, Inc.
Clover Biopharmaceuticals USA, LLC
Cogna Technology Solutions LLC
Coherus Oncology, Inc.
Compugen Ltd
Connect Biopharm LLC
Contineum Therapeutics
Corium Innovations, Inc.
Cullinan Therapeutics Inc.
Curevo Inc
CyanVac LLC
Cytokinetics
CytomX Therapeutics
D2M Biotherapeutics Inc.
D3 Bio (Wuxi) Co., Ltd
DalCor Pharmaceuticals
Danatlas Pharmaceuticals Co., Ltd
Dendreon
Desitin Arzneimittel GmbH
Dizal Pharmaceuticals
Dompe Farmaceutici S.p.A
Dr. Reddy's Laboratories Limited
DynamiCure Biotechnology
Egymedicalpedia
Eikon Therapeutics
Eisai Inc.
Empros Pharma AB
Enzene Biosciences Ltd.
Epkin
Evommune, Inc.
Evon Medics LLC
Expedition Therapeutics, Inc
Faraday Pharmaceuticals, Inc.
FBD Biologics Limited
Ferring Pharmaceuticals
Fosun Adgenvax Biopharmaceutical Co.,Ltd.
Fujian Akeylink Biotechnology Co., Ltd.
Galderma R&D
GCP-Service International West GmbH
Generate Biomedicines
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
GI Innovation, Inc.
Glenmark Specialty S.A.
Gritstone bio, Inc.
Guangzhou Excelmab Inc.
Guangzhou Fermion Technology Co., LTD
Guangzhou Lupeng Pharmaceutical Company LTD.
GV20 Therapeutics
Healthgen Biotechnology Corp.
HK inno.N Corporation
Huahui Health
Hummingbird Bioscience
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
ILiAD Biotechnologies
Immatics Biotechnologies GmbH
Immorna Biotherapeutics, Inc.
Immunocore Ltd
Impact Therapeutics, Inc.
Incendia Therapeutics
Inipharm Australia Pty Ltd
Insmed Incorporated
Inventprise Inc.
Invero Pharma, Inc.
Iterum Therapeutics, International Limited
iVascular S.L.U.
Janssen Pharmaceutical K.K.
Janux Therapeutics
Jason Ahee, M.D.
Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Jiangsu Genscend Biopharmaceutical Co., Ltd
Jiangsu Simcere Biologics Co., Ltd
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Kailera
Kardigan, Inc.
KeifeRx, LLC
Kinaset Therapeutics Inc
Klus Pharma Inc.
Kowa Company, Ltd.
Kunming Pharmaceuticals, Inc.
Kymab Limited
Laboratorio Avi-Mex, S.A. de C.V.
Laboratorios Richmond S.A.C.I.F.
LaNova Medicines Limited
LaNova Medicines Zhejiang Co., Ltd.
LaSanta S A S
Latigo Biotherapeutics
Lexaria Bioscience Corp.
Lexicon Pharmaceuticals
LG Chem
Lifordi Immunotherapeutics, Inc.
Locus Biosciences
Loxo Oncology, Inc.
Mabscale, LLC
Mabwell (Shanghai) Bioscience Co., Ltd.
MacroGenics
Marengo Therapeutics, Inc.
Medigen Vaccine Biologics Corp.
MedinCell S.A
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Mestag Therapeutics Limited
Minghui Pharmaceutical (Hangzhou) Ltd
Mirati Therapeutics Inc.
MOMA Therapeutics
MoonLake Immunotherapeutics AG
Mylan Pharmaceuticals Inc
Nektar Therapeutics
Neumora Therapeutics, Inc.
Neurodawn Pharmaceutical Co., Ltd.
Neuvosyn Laboratories, LLC
NextCure, Inc.
NiKang Therapeutics, Inc.
NovaOnco Therapeutics Co., Ltd.
Ollin Biosciences, Inc.
Omikron Italia S.r.l.
Oncomatryx Biopharma S.L.
OncoNano Medicine, Inc.
OnKure, Inc.
ONL Therapeutics
Onward Therapeutics
ORIC Pharmaceuticals
Parabilis Medicines, Inc.
Perha Pharmaceuticals
Pharmacosmos A/S
PHARMENTERPRISES LLC
Pheast Therapeutics
Pierre Fabre Medicament
Pliant Therapeutics, Inc.
Polpharma Biologics International AG
PPD Development, LP
Praxis Precision Medicines
Prestige Biopharma Limited
Protagonist Therapeutics, Inc.
PT. Kimia Farma (Persero) Tbk
PTC Therapeutics
PureTech
QED Therapeutics, a BridgeBio company
Qilu Pharmaceutical (Hainan) Co., Ltd.
Recardio, Inc.
Reistone Biopharma Company Limited
Riboscience, LLC.
Rondo Therapeutics
Sanaria Inc.
Sandoz
Sanotize Research and Development corp.
Sention Therapeutics, LLC
Shandong New Time Pharmaceutical Co., LTD
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Shanghai Vinnerna Biosciences Co., Ltd.
Shanghai Zerun Biotechnology Co.,Ltd
Shanghai Zhimeng Biopharma, Inc.
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Sichuan Purity Pharmaceutical Technology Co., Ltd.
SillaJen, Inc.
Sinovac Biotech (Colombia) S.A.S.
Sinovac Research and Development Co., Ltd.
Sirius Therapeutics Co., Ltd.
Sitryx Therapeutics Ltd
Sparrow Pharmaceuticals
Spero Therapeutics
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Sumitomo Pharma America, Inc.
Sumitomo Pharma Switzerland GmbH
Summit Therapeutics
Sutro Biopharma, Inc.
Suzhou Abogen Biosciences Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Synairgen Research Ltd.
Synnovation Therapeutics, Inc.
Synthekine
SystImmune Inc.
Taisho Pharmaceutical Co., Ltd.
Tarsus Pharmaceuticals, Inc.
Tasly Biopharmaceuticals Co., Ltd.
Tasly Pharmaceutical Group Co., Ltd
Terran Biosciences Australia Pty Ltd
TerSera Therapeutics LLC
Teva Pharmaceuticals USA
TG Therapeutics, Inc.
Tiohundra AB
Tonix Pharmaceuticals, Inc.
Totus Medicines
TScan Therapeutics, Inc.
TYK Medicines, Inc
United Therapeutics
Vac4All
Vaxart
Vaxxas Pty Ltd
Vera Therapeutics, Inc.
Vicore Pharma AB
Virogen Biotechnology Inc.
Werewolf Therapeutics, Inc.
Whitehawk Therapeutics, Inc.
Wockhardt
Xentria, Inc.
Yisheng Biopharma (Singapore) Pte. Ltd.
Zai Lab (Shanghai) Co., Ltd.
Zealand Pharma
Zhejiang Doer Biologics Co., Ltd.

Conditions

Targets